Get started
Author

Yuling Wu

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults
2016 · Xiang-Qing Yu, Gabriel J. Robbie, et al. · Antimicrobial Agents and Chemotherapy · 140
PDF
Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
2018 · S.O. Ali, X.Q. Yu, et al. · Clinical Microbiology and Infection · 133
PDF
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
2023 · Johanna Bendell, Patricia LoRusso, et al. · Cancer Immunology Immunotherapy · 124
PDF
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
2022 · Jean Chastre, Bruno François, et al. · Critical Care · 99
PDF
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial
2021 · Bruno François, Hasan S Jafri, et al. · The Lancet Infectious Diseases · 95
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies
2017 · Zhandong Don Zhong, Adrienne Clements-Egan, et al. · The AAPS Journal · 89
PDF
Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys
2010 · Jim J. Xiao, Wojciech Krzyzanski, et al. · The AAPS Journal · 81
PDF
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
2018 · Michael J. Overman, Patricia LoRusso, et al. · Journal of Clinical Oncology · 76
Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice
2018 · Grzegorz Kijanka, Jared S. Bee, et al. · Journal of Pharmaceutical Sciences · 75
PDF
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( Part 3 –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)
2021 · Bart Corsaro, Tong-yuan Yang, et al. · Bioanalysis · 62
PDF
Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893
2016 · David E. Tabor, Li Yu, et al. · Antimicrobial Agents and Chemotherapy · 59
Application of multi-factorial design of experiments to successfully optimize immunoassays for robust measurements of therapeutic proteins
2008 · Chad A. Ray, Vimal Patel, et al. · Journal of Pharmaceutical and Biomedical Analysis · 53
METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome
2022 · Yi Chen, Yuling Wu, et al. · Frontiers in Immunology · 52
PDF
Characterization of Alpha-Toxin hla Gene Variants, Alpha-Toxin Expression Levels, and Levels of Antibody to Alpha-Toxin in Hemodialysis and Postsurgical Patients with Staphylococcus aureus Bacteremia
2014 · Batu K. Sharma-Kuinkel, Yuling Wu, et al. · Journal of Clinical Microbiology · 50
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors
2020 · Lillian Siu, Joshua Brody, et al. · Journal for ImmunoTherapy of Cancer · 46
PDF
Recommendations for Adaptation and Validation of Commercial Kits for Biomarker Quantification in Drug Development
2015 · Masood U Khan, Ronald R Bowsher, et al. · Bioanalysis · 43
Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
2019 · Jingxian Duan, Yuling Wu, et al. · Journal of Hepatocellular Carcinoma · 39
PDF
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness ( Part 3 – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)
2022 · Lina Loo, Shannon Harris, et al. · Bioanalysis · 37
PDF
Characterisation of anti‐alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin
2018 · Alexey Ruzin, Yuling Wu, et al. · Clinical & Translational Immunology · 31
PDF
Neutralizing Antibody Validation Testing and Reporting Harmonization
2023 · Heather Myler, João Pedras-Vasconcelos, et al. · The AAPS Journal · 30
PDF
Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays
2012 · Robert J. Kubiak, Lanju Zhang, et al. · Journal of Pharmaceutical and Biomedical Analysis · 28
Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations
2017 · Yuling Wu, Xu Liu, et al. · Infection and Immunity · 24
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
2022 · Andrew Dippel, Austin Gallegos, et al. · mAbs · 21
An electrochemiluminescence (ECL)-based assay for the specific detection of anti-drug antibodies of the IgE isotype
2013 · Yuling Wu, Xu Liu, et al. · Journal of Pharmaceutical and Biomedical Analysis · 21
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo‐controlled OSTRO trial
2024 · Claire Emson, Joseph K. Han, et al. · British Journal of Clinical Pharmacology · 19
Works count: 58
Citation count: 1,724
H-index: 22
I10-index: 37
Year
Topic
Type